⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11687774 | 0.72 | — | — | |
| SCHEMBL6362527 | 0.67 | — | — | |
| SCHEMBL9617026 | 0.67 | — | — | |
| SCHEMBL379416 | 0.67 | — | — | |
| SCHEMBL5168525 | 0.67 | — | — | |
| SCHEMBL9543000 | 0.63 | — | — | |
| SCHEMBL16118582 | 0.62 | — | — | |
| SCHEMBL29139827 | 0.62 | — | — | |
| SCHEMBL8958348 | 0.50 | — | — | |
| SCHEMBL35245 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115175681-B | Use of sGC activators for the treatment of ophthalmic diseases | 拜耳公司 | 2024-10-25 | — | — | CN | disclosed |